Skip to main content

Navigation group

Type at least 3 characters
1,066 articles

Articles

Study Protocol

Published on 18 Jul 2024

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study

in Multiple Sclerosis and Neuroimmunology

  • Giovanna Borriello
  • Clara Grazia Chisari
  • Davide Maimone
  • Massimiliano Mirabella
  • Damiano Paolicelli
  • Francesco Assogna
  • Sandro Caradonna
  • Francesco Patti
Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study
Frontiers in Neurology
doi 10.3389/fneur.2024.1422078
  • 881 views

Original Research

Published on 27 Jun 2024

Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system

in Multiple Sclerosis and Neuroimmunology

  • Cristina Scavone
  • Antonietta Anatriello
  • Isabella Baccari
  • Andrea Cantone
  • Daniele Di Giulio Cesare
  • Francesca Futura Bernardi
  • Ornella Moreggia
  • Valerio Liguori
  • Vincenzo Andreone
  • Giorgia Teresa Maniscalco
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system
Frontiers in Neurology
doi 10.3389/fneur.2024.1383910
  • 1,036 views